During the past decade, Ranbaxy Research Laboratories conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ranbaxy Research Laboratories" are "Healthy" (4 trials). Many other conditions were trialed in "Ranbaxy Research Laboratories" in a lesser frequency.

Most popular intervention types in "Ranbaxy Research Laboratories" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Clarithromycin 250mg/5mL" (1 trials), "Nitrofurantoin 100 mg capsules" (1 trials), "clarithromycin 250 mg tablets" (1 trials) and "fenofibrate 160 mg tablets" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ranbaxy Research Laboratories" are 3 trials for "Male" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Ranbaxy Research Laboratories". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Ranbaxy Research Laboratories, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ranbaxy Research Laboratories, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".